Franklin Biotechnology Discovery Fund

6N5133EDK315FXQQM036

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: United States
Entity created: March 18, 2017

Address

Country: United States
Legal address: C/O The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street19801 WilmingtonUnited States (US-DE)
Head office: C/O Franklin Advisers, Inc., 1 Franklin Parkway94403 San MateoUnited States (US-CA)

Identifier

LEI: 6N5133EDK315FXQQM036
Registered: November 21, 2012 at 05:02 PM UTC
Last updated: July 2, 2026 at 07:29 PM UTC
Next renewal: July 17, 2027 at 12:19 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: EDGAR (RA000665)
Identifier: S000006882
Verified against: EDGAR (RA000665)
Verified as: S000006882
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

FRANKLIN ADVISERS, INC.
Fund managerUnited StatesB1CG1NRZIDDJ0DQEXB52
FRANKLIN STRATEGIC SERIES
Umbrella fundUnited States549300NDWC0J6DXVSX36

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/6N5133EDK315FXQQM036This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search